Ausgabe 5/2006
Inhalt (21 Artikel)
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial
Rupert Bartsch, Catharina Wenzel, Ursula Pluschnig, Dagmar Hussian, Ursula Sevelda, Gottfried J. Locker, Robert Mader, Christoph C. Zielinski, Guenther G. Steger
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer
Kathleen E. Rodgers, Jamie Oliver, Gere S. diZerega
CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines
Lori J. Pobst, Matthew M. Ames
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer
Yutaka Ogata, Keiko Matono, Teruo Sasatomi, Nobuya Ishibashi, Akira Ohkita, Tomoaki Mizobe, Shujiro Ogo, Satoru Ikeda, Hiroyuki Ozasa, Kazuo Shirouzu
Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion
Jianwen Liu, Xiaodong Zhang, Fan Yang, Ting Li, Dongzhi Wei, Yuhong Ren
Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin
Haifeng Song, Jin Zhang, Zhikai Han, Xueyan Zhang, Zheng Li, Lisheng Zhang, Ming Fu, Chen Lin, Jie Ma
Thalidomide does not interact with P-glycoprotein
Christian Zimmermann, Heike Gutmann, Juergen Drewe
Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl
Mao Li, Hui Wang, Donald L. Hill, Sherman Stinson, Karen Veley, Irma Grossi, James Peggins, Joseph M. Covey, Ruiwen Zhang
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients
Alessandra Fabi, Gianluigi Ferretti, Paola Papaldo, Nello Salesi, Mariangela Ciccarese, Vito Lorusso, Paolo Carlini, Armando Carpino, Marcella Mottolese, Anna Maria Cianciulli, Diana Giannarelli, Isabella Sperduti, Alessandra Felici, Francesco Cognetti
Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s and non-Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDE
Ketlin V. Pinheiro, Vania T. M. Hungria, Elisabeth S. Ficker, Claudete J. Valduga, Carlos H. Mesquita, Raul C. Maranhão
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors
William C. Zamboni, Sanjay Goel, Tahir Iqbal, Robert A. Parise, Sandra Strychor, Trisha V. W. Repinski, Merrill J. Egorin, Sridhar Mani
High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer
V. Heinemann, H. J. Stemmler, A. Wohlrab, D. Bosse, C. Losem, S. Kahlert, G. Rauthe
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
Takuji Okusaka, Hiroshi Ishii, Akihiro Funakoshi, Kenji Yamao, Shinichi Ohkawa, Soh Saito, Hiroshi Saito, Toshio Tsuyuguchi
Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice
Thomas Schluep, Jianjun Cheng, Kay T. Khin, Mark E. Davis
Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy
Maria Angélica O. Mendonça, Fernando Q. Cunha, Eddie Fernando C. Murta, Beatriz M. Tavares-Murta
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors
Matthew G. Fury, Lee M. Krug, Christopher G. Azzoli, Sunil Sharma, Nancy Kemeny, Nian Wu, Mark G. Kris, Naiyer A. Rizvi
A phase I study of monohydroxyethylrutoside in healthy volunteers
Anja M. Willems, Anne M. Bruynzeel, Marc A. Kedde, Cees J. van Groeningen, Aalt Bast, Wim J. van der Vijgh
Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics
Chetan Lathia, John Lettieri, Frank Cihon, Martha Gallentine, Martin Radtke, Pavur Sundaresan
Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models
Kaori F. -Ouchi, Mieko Yanagisawa, Fumiko Sekiguchi, Yutaka Tanaka
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
Paul H. Sugarbaker, O. Anthony Stuart, C. Pablo Carmignani